149 related articles for article (PubMed ID: 11028942)
1. The effect of gelatin cross-linking on the bioequivalence of hard and soft gelatin acetaminophen capsules.
Meyer MC; Straughn AB; Mhatre RM; Hussain A; Shah VP; Bottom CB; Cole ET; Lesko LL; Mallinowski H; Williams RL
Pharm Res; 2000 Aug; 17(8):962-6. PubMed ID: 11028942
[TBL] [Abstract][Full Text] [Related]
2. The effect of cross-linking on the in vivo disintegration of hard gelatin capsules.
Brown J; Madit N; Cole ET; Wilding IR; Cadé D
Pharm Res; 1998 Jul; 15(7):1026-30. PubMed ID: 9688055
[TBL] [Abstract][Full Text] [Related]
3. Cross-linking of hard gelatin carbamazepine capsules: effect of dissolution conditions on in vitro drug release.
Marchais H; Cayzeele G; Legendre JY; Skiba M; Arnaud P
Eur J Pharm Sci; 2003 Jun; 19(2-3):129-32. PubMed ID: 12791415
[TBL] [Abstract][Full Text] [Related]
4. Bioequivalence study of stressed and nonstressed hard gelatin capsules using amoxicillin as a drug marker and gamma scintigraphy to confirm time and GI location of in vivo capsule rupture.
Digenis GA; Sandefer EP; Page RC; Doll WJ; Gold TB; Darwazeh NB
Pharm Res; 2000 May; 17(5):572-82. PubMed ID: 10888309
[TBL] [Abstract][Full Text] [Related]
5. Dissolution testing of soft shell capsules-acetaminophen and nifedipine.
Bottom CB; Clark M; Carstensen JT
J Pharm Sci; 1997 Sep; 86(9):1057-61. PubMed ID: 9294822
[TBL] [Abstract][Full Text] [Related]
6. Cross-linking of gelatin capsules and its relevance to their in vitro-in vivo performance.
Digenis GA; Gold TB; Shah VP
J Pharm Sci; 1994 Jul; 83(7):915-21. PubMed ID: 7965669
[TBL] [Abstract][Full Text] [Related]
7. Soft, chewable gelatin-based pharmaceutical oral formulations: a technical approach.
Dille MJ; Hattrem MN; Draget KI
Pharm Dev Technol; 2018 Jun; 23(5):504-511. PubMed ID: 28532266
[TBL] [Abstract][Full Text] [Related]
8. Determination of extent of formaldehyde-induced crosslinking in hard gelatin capsules by near-infrared spectrophotometry.
Gold TB; Buice RG; Lodder RA; Digenis GA
Pharm Res; 1997 Aug; 14(8):1046-50. PubMed ID: 9279887
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of the dissolution characteristics of capsule and tablet dosage forms of melt granulations of paracetamol--diluent effects.
Uhumwangho MU; Okor RS
Acta Pol Pharm; 2007; 64(1):73-9. PubMed ID: 17665854
[TBL] [Abstract][Full Text] [Related]
10. Comparison of WHO and US FDA biowaiver dissolution test conditions using bioequivalent doxycycline hyclate drug products.
Strauch S; Jantratid E; Dressman JB
J Pharm Pharmacol; 2009 Mar; 61(3):331-7. PubMed ID: 19222905
[TBL] [Abstract][Full Text] [Related]
11. Crosslinking studies in gelatin capsules treated with formaldehyde and in capsules exposed to elevated temperature and humidity.
Ofner CM; Zhang YE; Jobeck VC; Bowman BJ
J Pharm Sci; 2001 Jan; 90(1):79-88. PubMed ID: 11064381
[TBL] [Abstract][Full Text] [Related]
12. Comparative in vivo bioequivalence and in vitro dissolution of two cyclosporin A soft gelatin capsule formulations.
Avramoff A; Laor A; Kitzes-Cohen R; Farin D; Domb AJ
Int J Clin Pharmacol Ther; 2007 Feb; 45(2):126-32. PubMed ID: 17323793
[TBL] [Abstract][Full Text] [Related]
13. A Novel Acetaminophen Soft-Chew Formulation Produced via Hot-Melt Extrusion with In-line Near-Infrared Monitoring as a Process Analytical Technology Tool.
Xu P; Zhang J; Bandari S; Repka MA
AAPS PharmSciTech; 2020 Jan; 21(2):37. PubMed ID: 31897804
[TBL] [Abstract][Full Text] [Related]
14. Influence of capsule shell composition on the performance indicators of hypromellose capsule in comparison to hard gelatin capsules.
Al-Tabakha MM; Arida AI; Fahelelbom KM; Sadek B; Saeed DA; Abu Jarad RA; Jawadi J
Drug Dev Ind Pharm; 2015; 41(10):1726-37. PubMed ID: 25586554
[TBL] [Abstract][Full Text] [Related]
15. The influence of polymorphism on the manufacturability and in vitro dissolution of sulindac-containing hard gelatin capsules.
Guadalupe Sánchez-González E; Yépez-Mulia L; Jesús Hernández-Abad V; Jung Cook H
Pharm Dev Technol; 2015 May; 20(3):306-13. PubMed ID: 24417644
[TBL] [Abstract][Full Text] [Related]
16. Biowaiver monographs for immediate release solid oral dosage forms: acetaminophen (paracetamol).
Kalantzi L; Reppas C; Dressman JB; Amidon GL; Junginger HE; Midha KK; Shah VP; Stavchansky SA; Barends DM
J Pharm Sci; 2006 Jan; 95(1):4-14. PubMed ID: 16307451
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo pharmacoscintigraphic evaluation of ibuprofen hypromellose and gelatin capsules.
Cole ET; Scott RA; Cade D; Connor AL; Wilding IR
Pharm Res; 2004 May; 21(5):793-8. PubMed ID: 15180336
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
[TBL] [Abstract][Full Text] [Related]
19. Effect of glycine/citric acid on the dissolution stability of hard gelatin capsules.
Adesunloye TA; Stach PE
Drug Dev Ind Pharm; 1998 Jun; 24(6):493-500. PubMed ID: 9876614
[TBL] [Abstract][Full Text] [Related]
20. Development of a two-step tier-2 dissolution method for blinded overencapsulated erlotinib tablets using UV fiber optic detection.
Lu X; Xiao B; Lo L; Bolgar MS; Lloyd DK
J Pharm Biomed Anal; 2011 Aug; 56(1):23-9. PubMed ID: 21620602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
